Diabetic retinopathy in Africa: Advantages of screening

Postgraduate Medicine

Volumn 123, Issue 4, 2011, Pages 119-125

  Guigui, Sarah ^a   Lifshitz, Tova ^a   Levy, Jaime ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Africa; Diabetes; Diabetic retinopathy

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LIPID; SULFONYLUREA;

ADULT; AFRICA; AGE; BLOOD PRESSURE REGULATION; CAREGIVER; CLINICAL ASSESSMENT TOOL; COMMUNITY CLINIC; COST UTILITY ANALYSIS; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; EDUCATION PROGRAM; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CENTER; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HOSPITAL PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; LIPID BLOOD LEVEL; MALE; MEDICAL EDUCATION; MEDICAL SPECIALIST; MICROANEURYSM; MICROANGIOPATHY; MORTALITY; MYDRIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NON MYDRIATIC CAMERA; OPHTHALMOLOGIST; OPHTHALMOLOGY; OPHTHALMOSCOPY; PATIENT EDUCATION; PATIENT REFERRAL; PEER REVIEW; PREGNANCY; PREVALENCE; PRIMARY MEDICAL CARE; PROLIFERATIVE RETINOPATHY; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RETINAL PHOTOGRAPHY; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY; SINGLE FIELD FUNDUS PHOTOGRAPHY; STEREOSCOPIC COLOR FUNDUS PHOTOGRAPHY; VISUAL IMPAIRMENT;

AFRICA; DIABETIC RETINOPATHY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION AS TOPIC;

EID: 79960313767     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.07.2311     Document Type: Review

References (48)

1. American Academy of Ophthalmology Retina Panel. Preferred practice pattern guidelines. Diabetic retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008. June 2010. http://www.aao.org/ppp. Accessed May 4, 2011.
2. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab (Paris). 2001;27(6):628-634.
3. Mbanya JC, Cruickshank JK, Forrester T, et al. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999;22(3):434-440.
4. Arfken CL, Reno PL, Santiago JV, Klein R. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diab Care. 1998;21(5):792-795.
5. Aiello LM. Perspectives on diabetic retinopathy. Am J Ophthalmol. 2003;136(1):122-135.
6. Pai A, El Shafei M, Mohammed O, Al Hashimi M. Current concepts in intravitreal drug therapy for diabetic retinopathy. Saudi Journal of Ophthalmology. 2010;24:143-149.
7. Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78(4):374-385.
8. Lewallen S, Courtright P. Blindness in Africa: present situation and future needs. Br J Ophthalmol. 2001;85(8):897-903.
9. Read O, Cook C. Retinopathy in diabetic patients evaluated at a primary care clinic in Cape Town. SAMJ. 2007;97(10):941, 942, 944.
10. Levitt N. Diabetes in Africa. J Cardiovascular Risk. 2003;10:75-76.
11. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA. 2003;289(1):76-79.
12. Rotimi C, Daniel H, Zhou J, et al. Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethn Dis. 2003;13(2 suppl 2):S110-S117.
13. Gebre-Yohannes A, Rahlenbeck SI. Glycemic control and its determinants in diabetic patients in Ethiopia. Diabetes Res Clin Pract. 1997;35(2-3):129-134.
14. Sobngwi E, Mbanya JC, Moukouri EN, et al. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44(3):191-196.
15. Seyoum B, Mengitsu Z, Berhanu P, et al. Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J. 2001;39(2):123-131.
16. Erasmus RT, Alanamu RA, Bojuwoye B, et al. Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment, and degree of control. East Afr Med J. 1989;66(4):248-254.
17. Kaimbo DK, Kabongo DK, Missotten L. Ocular complications in diabetes mellitus in Zaire. Bull Soc Belge Ophtalmol. 1995;255:107-113.
18. Drabo PY, Kabore J, Lengani A. Complications of diabetes mellitus at the Hospital Center of Ouagadougou. Bull Soc Pathol Exot. 1996;89(3):191-195.
19. Lester FT. Clinical features, complications, and mortality in type 2 (non-insulin dependent) diabetic patients in Addis Ababa, Ethiopia. Ethiop Med J. 1993;31(2):109-126.
20. Mbanya JC, Sobngwi E. Diabetes microvascular and macrovascular disease in Africa. J Cardiovasc Risk. 2003;10(2):97-102.
21. Rahlenbeck SI, Gebre-Yohannes A. Prevalence and epidemiology of micro-and macroalbuminuria in Ethiopian diabetic patients. J Diabet Complic. 1997;11(6):343-349.
22. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet. 2006;368(9548):1689-1695.
23. Gill G, Gebrekidan A, English P, Wile D, Tesfaye S. Diabetic complications and glycaemic control in remote North Africa. Q J Med. 2008;101(10):793-798.
24. Dagogo-Jack S. Primary prevention of type-2 diabetes in developing countries. J Natl Med Assoc. 2006;98(3):415-519.
25. Onakpoya OH, Adeoye AO, Kolawole BA. Determinants of previous dilated eye examination among type II diabetics in Southwestern Nigeria. Eur J Intern Med. 2010;21:176-179.
26. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44(8):968-983.
27. White NH, Sun W, Cleary PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol. 2008;126(12):1707-1715.
28. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
29. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-713.
30. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796-1806.
31. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology. 1989;96(2):255-164.
32. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1 pt 2):164-169.
33. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The costeffectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol. 2000;11:175-179.
34. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000;320(7246):1373-1378.
35. Standards of Medical Care in Diabetes 2009. Diabetes Care. 2010;33(suppl 1):S11.
36. Peters AL, Legoretta AP, Ossario RC, Davidson MB. Quality of outpatient care provided to diabetic patients: a health maintenance organization experience. Diabetes Care. 1996;19(6):601-606.
37. Stern E, Benbassat CA, Goldfracht M. Impact of a two-arm educational program for improving diabetes care in primary care centres. Int J Clin Pract. 2005;59(10):1126-1130.
38. Mash B, Powell D, du Plessis F, van Vuuren U, Michalowska M, Levitt N. Screening for diabetic retinopathy in primary care with a mobile fundal camera-evaluation of a South African pilot project. S Afr Med J. 2007;97(12):1284-1288.
39. Carmichael TR, Carp GI, Welsh ND, Kalk WJ. Effective and accurate screening for diabetic retinopathy using a 60° mydriatic fundus camera. S Afr Med J. 2005;95(1):57-61.
40. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 suppl):786-806.
41. Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald R. Single-field fundus photography for diabetic retinopathy screening. Ophthalmology. 2004;111(5):1055-1062.
42. Massin P, Erginay A, Ben Mehidi A, et al. Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med. 2003;20(8):635-641.
43. Massin P, Aubert JP, Eschwege E, et al. Evaluation of a screening program for diabetic retinopathy in a primary care setting Dodia (Dépistage ophtalmologique du diabète) study. Diabetes Metab. 2005;31(2):153-162.
44. Baeza M, Orozco-Beltran D, Gil-Guillen VF, et al. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate? Int J Clin Pract. 2009;63(3):433-428.
45. Harding S, Garvican L, Talbot J. The impact of national diabetic retinopathy screening on ophthalmology: the need for urgent planning. Eye. 2005;19(9):1009-1011.
46. Leese GP, Ahmed S, Newton RW, et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ. 1993;306(6871):187-189.
47. Sculpher M, Buxton M, Fergusson B, Humphreys J, Altman J, Spiegelhalter D. A relative cost effectiveness analysis of different methods of screening for diabetic retinopathy. Diabetic Med. 1991;8(7):644-650.
48. Luzio S, Hatcher S, Zahlmann G, et al. Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy. Diabetic Medicine. 2004;21(10):1121-1128.